tiprankstipranks
CytoDyn (CYDY)
OTHER OTC:CYDY
US Market

CytoDyn (CYDY) Income Statement

Compare
655 Followers

CytoDyn Income Statement

Last quarter (Q2 2025), CytoDyn's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, CytoDyn's net income was $-4.77M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 266.00K$ 0.00$ 0.00
Gross Profit
$ -29.00K$ -175.00K$ 213.00K$ -1.80M$ -2.03M
Operating Expenses
$ 18.06M$ 40.40M$ 72.13M$ 94.55M$ 74.65M
Depreciation and Amortization
$ 29.00K$ 175.00K$ 781.00K$ 1.80M$ 2.03M
EBITDA
$ -18.03M$ -40.40M$ -192.55M$ -92.75M$ 2.03M
Operating Income
$ -18.06M$ -40.58M$ -71.91M$ -104.60M$ -74.65M
Other Income/Expenses
$ -31.78M$ -39.25M$ -65.42M$ -50.08M$ -49.76M
Pretax Income
$ -49.84M$ -79.82M$ -210.82M$ -154.67M$ -124.40M
Net Income
$ -49.84M$ -79.82M$ -288.16M$ -174.02M$ -141.78M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.05$ -0.10$ -0.43$ -0.30$ -0.34
Diluted EPS
$ -0.05$ -0.10$ -0.43$ -0.30$ -0.34
Weighted Average Shares Outstanding
969.51M 836.53M 676.90M 587.59M 421.08M
Weighted Average Shares Outstanding (Diluted)
969.51M 836.53M 676.90M 587.59M 421.08M
Currency in USD

CytoDyn Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis